| Literature DB >> 30927518 |
Bas Hilberdink1, Florus van der Giesen1, Thea Vliet Vlieland1, Floris van Gaalen1, Salima van Weely1.
Abstract
OBJECTIVE: Supervised group exercise (SGE) has been proven effective in patients with axial spondyloarthritis (SpA), but its contents and dosage do not always comply with current scientific insight. This aim of this study was to describe axial SpA patients' satisfaction with current SGE and perspective on potential evidence-based SGE enhancements.Entities:
Year: 2020 PMID: 30927518 PMCID: PMC7317594 DOI: 10.1002/acr.23892
Source DB: PubMed Journal: Arthritis Care Res (Hoboken) ISSN: 2151-464X Impact factor: 4.794
Characteristics of axial SpA patients participating in SGE in 4 regions in The Netherlandsa
| Overall (n = 118) | R1 (n = 43) | R2 (n = 17) | R3 (n = 35) | R4 (n = 23) |
| |
|---|---|---|---|---|---|---|
| Female sex | 42 (35.6) | 12 (27.9) | 7 (41.2) | 14 (40) | 9 (39.1) | 0.62 |
| Age, mean ± SD years | 59.7 ± 11.6 | 58.5 ± 12.8 | 56.2 ± 11.6 | 62.6 ± 10.3 | 60.2 ± 10.7 | 0.24 |
| Disease duration, mean ± SD years | 24.9 ± 14.2 | 25.1 ± 17.7 | 24.1 ± 8.5 | 24.9 ± 11.1 | 25.0 ± 15.3 | 0.99 |
| Medication use | ||||||
| Painkiller | 28 (23.7) | 10 (23.3) | 6 (35.3) | 7 (20.0) | 5 (21.7) | 0.66 |
| NSAID | 64 (54.2) | 25 (58.1) | 4 (23.5) | 21 (60.0) | 14 (60.9) | 0.06 |
| DMARD | 10 (8.5) | 3 (7.0) | 1 (5.9) | 2 (5.7) | 4 (17.4) | 0.40 |
| Biologic | 19 (16.1) | 5 (11.6) | 4 (23.5) | 6 (17.1) | 4 (17.4) | 0.71 |
| None | 27 (22.9) | 7 (16.3) | 5 (29.4) | 9 (25.7) | 6 (26.1) | 0.22 |
| Days per week active ≥30 minutes | ||||||
| Mean ± SD days | 4.8 ± 2.2 | 4.5 ± 2.3 | 4.9 ± 2.1 | 4.9 ± 2.1 | 5.5 ± 2.0 | 0.40 |
| ≥5 days, no./total no. (%) | 66/107 (61.7) | 21/39 (53.8) | 8/13 (61.5) | 20/33 (60.6) | 17/22 (77.3) | 0.22 |
| SGE, mean ± SD years | 17.8 ± 9.9 | 14.7 ± 9.1 | 20.7 ± 10.0 | 20.8 ± 10.4 | 17.0 ± 9.4 | 0.03 |
| Reimbursement | ||||||
| Full | 52 (44.1) | 41 (95.3) | 1 (5.9) | 6 (17.1) | 4 (17.4) | <0.001 |
| Partial | 18 (15.3) | 2 (4.7) | 4 (23.5) | 5 (14.3) | 7 (30.4) | 0.03 |
| None | 48 (40.7) | 0 (0) | 12 (70.6) | 24 (68.6) | 12 (52.2) | <0.001 |
Values are the number (%) unless indicated otherwise. SpA = spondyloarthritis; SGE = supervised group exercise; NSAID = nonsteroidal antiinflammatory drug; DMARD = disease‐modifying antirheumatic drug.
P value of chi‐square test for categorical data and of one‐way analysis of variance for continuous data. P < 0.05 indicates a significant difference between the 4 regions.
Experiences and satisfaction of axial SpA patients with current SGE in 4 regions in The Netherlandsa
| Overall (n = 118) | R1 (n = 43) | R2 (n = 17) | R3 (n = 35) | R4 (n = 23) |
| |
|---|---|---|---|---|---|---|
| Overall intensity | ||||||
| Too high | 11/112 (9.8) | 4/41 (9.8) | 0/14 (0) | 5/34 (14.7) | 2/23 (8.7) | 0.43 |
| Just right | 84/112 (75) | 31/41 (75.6) | 11/14 (78.6) | 27/34 (79.4) | 15/23 (65.2) | 0.71 |
| Too low | 17/112 (15.2) | 6/41 (14.6) | 3/14 (21.4) | 2/34 (5.9) | 6/23 (26.1) | 0.18 |
| Overall duration | ||||||
| Minutes | 115 | 135 | 100 | 135 | 90 | |
| Too long | 9/111 (8.1) | 5/41 (12.2) | 1/15 (6.7) | 3/32 (9.4) | 0/23 (0) | 0.39 |
| Just right | 93/111 (83.8) | 36/41 (87.8) | 12/15 (80) | 28/32 (87.5) | 17/23 (73.9) | 0.64 |
| Too short | 9/111 (8.1) | 0/41 (0) | 2/15 (13.3) | 1/32 (3.1) | 6/23 (26.1) | 0.001 |
| Overall load | ||||||
| Too heavy | 15/117 (12.8) | 6/43 (14) | 1/17 (5.9) | 4/34 (11.4) | 4/23 (17.4) | 0.73 |
| Just right | 89/117 (76.1) | 31/43 (72.1) | 12/17 (70.6) | 29/34 (82.9) | 17/23 (73.9) | 0.67 |
| Too easy | 13/117 (11.1) | 6/43 (14) | 4/17 (23.6) | 1/34 (2.9) | 2/23 (9.7) | 0.13 |
| Mobility exercises | ||||||
| Too much attention | 2/114 (1.8) | 0/41 (0) | 0/15 (0) | 2/35 (5.7) | 0/23 (0) | 0.19 |
| Just right attention | 102/114 (89.5) | 37/41 (90.2) | 11/15 (73.3) | 32/35 (91.4) | 22/23 (95.7) | 0.03 |
| Too little attention | 10/114 (8.8) | 4/41 (9.8) | 4/15 (26.7) | 1/35 (2.9) | 1/23 (4.3) | 0.07 |
| Strengthening exercises | ||||||
| Too much attention | 1/115 (0.9) | 0/42 (0) | 0/15 (0) | 1/35 (2.9) | 0/23 (0) | 0.50 |
| Enough attention | 90/115 (78.3) | 32/42 (76.2) | 11/15 (73.3) | 28/35 (80) | 19/23 (82.6) | 0.55 |
| Too little attention | 24/115 (20.9) | 10/42 (23.8) | 4/15 (26.7) | 6/35 (17.1) | 4/23 (17.4) | 0.88 |
| Cardiorespiratory exercises | ||||||
| Too much attention | 1/114 (0.9) | 1/42 (2.4) | 0/15 (0) | 0/35 (0) | 0/22 (0) | 0.62 |
| Enough attention | 82/114 (71.9) | 29/42 (69) | 11/15 (73.3) | 28/35 (80) | 14/22 (63.6) | 0.37 |
| Too little attention | 31/114 (27.2) | 12/42 (28.6) | 4/15 (26.7) | 7/35 (20) | 8/22 (36.4) | 0.64 |
| Opportunities personal exercise | ||||||
| Too little | 18/116 (15.5) | 9/43 (20.9) | 0/16 (0) | 4/35 (11.4) | 5/22 (22.7) | 0.15 |
| Sufficient | 49/116 (42.2) | 20/43 (46.5) | 9/16 (56.3) | 11/35 (31.4) | 9/22 (40.9) | 0.41 |
| Not necessary | 49/116 (42.2) | 14/43 (32.6) | 7/16 (43.8) | 20/35 (57.1) | 8/22 (36.4) | 0.15 |
| Experienced effects | ||||||
| No deterioration | 96/118 (81.4) | 32/43 (74.4) | 14/17 (82.4) | 29/35 (82.9) | 21/23 (91.3) | 0.40 |
| Less stiffness | 70/118 (59.3) | 26/43 (60.5) | 11/17 (64.7) | 16/35 (45.7) | 17/23 (73.9) | 0.18 |
| More endurance | 31/118 (26.3) | 13/43 (30.2) | 5/17 (29.4) | 8/35 (22.9) | 5/23 (21.7) | 0.83 |
| Less pain | 23/118 (19.5) | 10/43 (23.3) | 3/17 (17.6) | 6/35 (17.1) | 4/23 (17.4) | 0.89 |
| More strength | 21/118 (17.8) | 7/43 (16.3) | 3/17 (17.6) | 6/35 (17.1) | 5/23 (21.7) | 0.96 |
| Less medication | 20/118 (16.9) | 9/43 (20.9) | 2/17 (11.8) | 6/35 (17.1) | 3/23 (13) | 0.79 |
| Other | 34/118 (28.8) | 14/43 (32.6) | 8/17 (47.1) | 7/35 (20) | 5/23 (21.7) | 0.18 |
| None | 4/118 (3.4) | 2/43 (4.7) | 0/17 (0) | 2/35 (5.7) | 0/23 (0) | 0.53 |
| SGE grade | ||||||
| Median (IQR) | 7 (7–8) | 8 (7–8) | 7 (6–8) | 8 (7–8) | 7 (7–8) | 0.47 |
| Grade ≥7 | 103/118 (87.2) | 36/43 (83.7) | 12/17 (70.6) | 34/35 (97.2) | 20/23 (91.2) | 0.04 |
Values are the number/total number (%) of participants unless indicated otherwise. SpA = spondyloarthritis; SGE = supervised group exercise; IQR = interquartile range.
P value of chi‐square test for categorical data and of one‐way analysis of variance for continuous data. P < 0.05 indicates a significant difference between the 4 regions.
Participants' perspective on potential, evidence‐based enhancements of SGE for axial SpA patients in 4 regions of The Netherlandsa
| Overall (n = 118) | R1 (n = 43) | R2 (n = 17) | R3 (n = 35) | R4 (n = 23) |
| |
|---|---|---|---|---|---|---|
| Periodic reassessment, in favor | 97/118 (82.2) | 31/43 (72.1) | 16/17 (94.1) | 28/35 (80) | 22/23 (95.7) | 0.06 |
| Heart‐rate monitoring, in favor | 97/117 (82.9) | 27/43 (62.8) | 14/17 (82.4) | 34/35 (97.1) | 22/22 (100) | <0.001 |
| Exercise more frequently, in favor | 73/116 (62.4) | 19/42 (45.2) | 14/16 (87.5) | 19/35 (54.3) | 21/23 (91.3) | <0.001 |
| Education axial SpA and exercise, in favor | 37/74 (50) | NA | 13/16 (81.3) | 16/35 (45.7) | 8/23 (34.8) | 0.01 |
| Importance of expert guidance | ||||||
| Extremely important | 51/118 (43.2) | 16/43 (37.2) | 10/17 (58.8) | 15/35 (42.9) | 10/23 (43.5) | 0.51 |
| Very important | 54/118 (45.8) | 21/43 (48.8) | 6/17 (35.3) | 16/35 (45.7) | 11/23 (47.8) | 0.81 |
| Neutral | 11/118 (9.3) | 4/43 (9.3) | 1/17 (5.9) | 4/35 (11.4) | 2/23 (8.7) | 0.93 |
| Unimportant | 1/118 (0.8) | 1/43 (2.3) | 0/17 (0) | 0/35 (0) | 0/23 (0) | 0.62 |
| Very unimportant | 0/118 (0) | 0/43 (0) | 0/17 (0) | 0/35 (0) | 0/23 (0) | NA |
Values are the number/total number (%) of participants unless indicated otherwise. SGE = supervised group exercise; SpA = spondyloarthritis; NA = not applicable.
P value of chi‐square test for categorical data and of one‐way analysis of variance for continuous data. P < 0.05 indicates a significant difference between the 4 regions.
In region 1 (R1), the view on heart‐rate monitoring during 20–30 minutes of bike exercise was asked, and in the other regions, just the view on heart‐rate monitoring was asked.
Not measured in R1.
Specific views on nature of guidance duration and frequency of additional exercise besides current SGE of participants in Region 1a
| R1 (n = 43) | |
|---|---|
| Exercise more often | |
| SGE twice a week | 10 (23.3) |
| SGE combined with an alternative individual or group exercise activity | 19 (45.2) |
| Delivery of additional individual exercise | |
| From leaflet or internet | 3 (7.0) |
| Personally tailored | 10 (23.3) |
| From app or DVD | 6 (14.0) |
| Remote, interactive guidance (through app, online, or e‐mail) | 4 (9.3) |
| On own initiative | 6 (14.0) |
| Not in favor of individual exercise | 8 (18.6) |
| Delivery of additional guided exercise | |
| Regular sport with non‐axial SpA–specific guidance | 1 (2.3) |
| Another axial SpA–specific group exercise activity | 6 (14.0) |
| Axial SpA–specific exercise with online webcam guidance | 2 (4.7) |
| Personally tailored exercise program with expert guidance | 7 (16.3) |
| Not in favor of another organized exercise activity | 7 (16.3) |
| Duration additional exercise | |
| <1 hour | 1 (2.3) |
| 1 hour | 6 (14.0) |
| 1.5 hours | 8 (18.6) |
| >1.5 hours | 2 (4.7) |
| Frequency of additional exercise (besides current SGE) | |
| 1 extra weekly session | 12 (27.9) |
| 2 extra weekly sessions | 4 (9.3) |
| 3 extra weekly sessions | 0 (0) |
| >3 extra weekly sessions | 0 (0) |
| Willingness to pay at most for 1 session of additional exercise (n = 16) | |
| Median amount (IQR) | €7.00 (€5–€10) |
| Most often reported amount, no. (%) | €10.00 (5 [31]) |
Values are the number (%) unless indicated otherwise. SGE = supervised group exercise; SpA = spondyloarthritis; IQR = interquartile range.